Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy, Overweight and/or Obese Subjects”

36 trials

Showing 20 of 36 results

Early research (Phase 1)Temporarily pausedNCT06739707
What this trial is testing

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

Who this might be right for
Healthy Volunteer
Cohen Global, Ltd. 54
Not applicableUnknownNCT03774095
What this trial is testing

Effect of Dietary Oils as G-protein-coupled Receptor Agonists on Glucose Tolerance

Who this might be right for
Type 2 Diabetes MellitusObesity
Karina Vejrum Sørensen 10
Early research (Phase 1)Study completedNCT05511025
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese

Who this might be right for
Healthy Participants
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT05762471
What this trial is testing

Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 142
Early research (Phase 1)Study completedNCT00976105
What this trial is testing

Effects of Repeat Dosing of GSK1521498

Who this might be right for
Obesity
GlaxoSmithKline 49
Early research (Phase 1)Ended earlyNCT01764425
What this trial is testing

Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

Who this might be right for
Healthy, Overweight and/or Obese Subjects
Piramal Enterprises Limited 32
Early research (Phase 1)Looking for participantsNCT07239973
What this trial is testing

BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

Who this might be right for
HealthyNon-diabetic Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd. 75
Early research (Phase 1)Looking for participantsNCT06859853
What this trial is testing

Evaluate MWN109 Injection in Healthy Subjects

Who this might be right for
Overweight or Obese
Shanghai Minwei Biotechnology Co., Ltd 72
Early research (Phase 1)Active Not RecruitingNCT07514260
What this trial is testing

Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.

Who this might be right for
Healthy Volunteer
AbbVie 24
Early research (Phase 1)Not Yet RecruitingNCT07794111
What this trial is testing

A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.

Who this might be right for
Obesity / Overweight
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 108
Early research (Phase 1)Study completedNCT03775278
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects

Who this might be right for
Otherwise Healthy Overweight or Obese
pH Pharma 50
Early research (Phase 1)Not Yet RecruitingNCT07337174
What this trial is testing

Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects

Who this might be right for
Obesity
Huons Co., Ltd. 40
Early research (Phase 1)Ended earlyNCT01614782
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Study completedNCT03385369
What this trial is testing

Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent

Who this might be right for
SafetyHealthy Subjects
MedImmune LLC 32
Early research (Phase 1)Study completedNCT02692781
What this trial is testing

A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects

Who this might be right for
Obesity
OPKO Health, Inc. 32
Early research (Phase 1)Study completedNCT05310032
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses

Who this might be right for
Obesity
Glaceum 36
Early research (Phase 1)Not Yet RecruitingNCT07784699
What this trial is testing

GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants

Who this might be right for
Healthy Subjects;Overweight or Obesity
Gan & Lee Pharmaceuticals. 112
Early research (Phase 1)Study completedNCT01474941
What this trial is testing

PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects

Who this might be right for
Healthy
Pfizer 27
Early research (Phase 1)Study completedNCT06200467
What this trial is testing

Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

Who this might be right for
OverweightObesity
Boehringer Ingelheim 110
Early research (Phase 1)Looking for participantsNCT07102251
What this trial is testing

Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects

Who this might be right for
Healthy Subjects
Sunshine Lake Pharma Co., Ltd. 126
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation